Chromatine/Épigénétique
Les inhibiteurs de la chromatine/épigénétique sont des composés qui modulent la structure et la fonction de la chromatine ou interfèrent avec les modifications épigénétiques, telles que la méthylation de l'ADN et la modification des histones. Ces inhibiteurs sont des outils essentiels pour étudier la régulation de l'expression génique et le rôle de l'épigénétique dans des maladies telles que le cancer, les troubles neurologiques et les anomalies du développement. En ciblant les processus épigénétiques, ces inhibiteurs peuvent modifier les schémas d'expression génique et offrir de nouvelles perspectives thérapeutiques. Chez CymitQuimica, nous offrons une large sélection d'inhibiteurs de la chromatine/épigénétique de haute qualité pour soutenir vos recherches en biologie moléculaire, génétique et épigénétique.
Sous-catégories appartenant à la catégorie "Chromatine/Épigénétique"
2613 produits trouvés pour "Chromatine/Épigénétique"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
MR44397
MR44397 is a ligand for WD40 repeat (WDR) 5 and is applicable in cancer research.Formule :C23H26N4O2SCouleur et forme :SolidMasse moléculaire :422.54HDAC-IN-80
HDAC-IN-80 (compound 5) is a selective inhibitor of class I HDAC.Couleur et forme :Odour SoliddBRD9
CAS :dBRD9 is a PROTAC.Formule :C40H45N7O10Degré de pureté :99.81%Couleur et forme :SolidMasse moléculaire :783.83Ref: TM-T31221
1mg129,00€5mg311,00€1mL*10mM (DMSO)434,00€10mg502,00€25mg874,00€50mg1.320,00€100mg1.833,00€coumarin-SAHA
CAS :SAHA inhibits class I/II HDAC; c-SAHA, a fluorescent derivative, excites at 325 nm and emits at 400 nm.Formule :C18H22N2O5Couleur et forme :SolidMasse moléculaire :346.383PROTAC BET Degrader-1
CAS :PROTAC BET Degrader-1 is a potent degrader of BET based on PROTAC.Formule :C44H45N11O9Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :871.9DBL-6-13
DBL-6-13 is an inhibitor of WDR5, displaying moderate binding affinity with dissociation constants (Kd) of 6.8 μM and 9.1 μM as determined by microscale thermophoresis analysis and fluorescence polarization analysis, respectively.Formule :C25H38N4O3Couleur et forme :SolidMasse moléculaire :442.59METTL16-IN-1
METTL16-IN-1 is a potent inhibitor of METTL16, with an IC50 value of 1.7 μM and a Kd value of 1.35 μM. It effectively suppresses the binding of U6 snRNA deletion to the METTL16 MTD, with an IC50 value of 2.5 μM. METTL16-IN-1 also exhibits antitumor activity.Formule :C19H12BrN3O6S2Masse moléculaire :520.93509CDD-1102 HCl
CDD-1102 HCl is a novel BRDT-BD4 / BRD2-BD1302 selective inhibitor that shows non-hormonal contraceptive potential in ex vivo experiments.Formule :C32H31ClN6O3Degré de pureté :98.30%Couleur et forme :SoildMasse moléculaire :583.08Myelin Basic Protein TFA
MHP4-14 TFA, synthetic peptide 4-14 of myelin, selective PKC substrate (Km=7μM), not phosphorylated by other kinases.Formule :C62H104F3N21O19Couleur et forme :SolidMasse moléculaire :1504.61Fibrostatin C
CAS :Fibrostatin C is an inhibitor of prolyl 4-hydroxylase. It is produced by Streptomyces catenulae subsp.Formule :C18H19NO8SCouleur et forme :SolidMasse moléculaire :409.41iRucaparib-AP6
CAS :iRucaparib-AP6: a specific, non-trapping PARP1 degrader; inhibits the enzyme's activity and scaffolding.Formule :C46H55FN6O11Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :886.96PRMT5-IN-12
CAS :PRMT5-IN-12 shows remarkable inhibitory activity on PRMT5 .Formule :C32H40N4O4Couleur et forme :SolidMasse moléculaire :544.696PI3Kα/HDAC6-IN-1
PI3Kα/HDAC6-IN-1 (compound 21j) is a dual inhibitor of PI3Kα and HDAC6, exhibiting IC50 values of 2.9 nM and 26 nM, respectively.Formule :C27H30F3N7O6S2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :669.7Bryostatin 2
CAS :Protein kinase C (PKC) activatorFormule :C45H66O16Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :863PROTAC BRD4 Degrader-5-CO-PEG3-N3
CAS :PROTAC BRD4 Degrader-5-CO-PEG3-N3 is a PROTAC-linker conjugate for PAC. PROTAC BRD4 Degrader-5-CO-PEG3-N3 comprises the BRD4 degrader GNE-987 linked through a PEG-based spacer to enable modular bioconjugation. PROTAC BRD4 Degrader-5-CO-PEG3-N3 functions as a click-chemistry reagent containing an azide group capable of undergoing copper-catalyzed azide-alkyne cycloaddition (CuAAC) with alkyne-bearing molecules. PROTAC BRD4 Degrader-5-CO-PEG3-N3 can also react through strain-promoted alkyne-azide cycloaddition (SPAAC) with DBCO- or BCN-containing compounds, thereby supporting targeted PROTAC assembly and bioconjugation for chemical biology and drug-discovery applications.Formule :C58H75ClN12O12S2Degré de pureté :99.17%Couleur et forme :SolidMasse moléculaire :1231.87NUCC-0226272
CAS :NUCC-0226272, a potent PROTAC, induces the degradation of EZH2 and exhibits anti-proliferative effects. It holds promise for application in cancer research [1].Formule :C67H91N9O8SCouleur et forme :SolidMasse moléculaire :1182.56HIV-1 protease-IN-10
HIV-1 protease-IN-10 (Compound 2), exhibiting HIV-1 latency reversing activity (IC50: 0.22 μM), selectively binds to the PKCδ C1b domain (IC50: 0.69 μM) andFormule :C23H40O5Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :396.56PROTAC BRD4 Degrader-37
PROTACBRD4 Degrader-37 is a PROTACBRD4 degrader with a DC50 of 36.4 nM and a Dmax of 73% in PANC-1 cells. It exhibits cytotoxicity against PANC-1 cells with a GI50 of 0.282 μM. PROTACBRD4 Degrader-37 is applicable for cancer research.Couleur et forme :Odour SolidPROTAC SMARCA2/4-degrader-34
PROTAC SMARCA2/4-degrader-34 (compound 38) serves as an effective degrader of both SMARCA2 and SMARCA4. It demonstrates binding affinity to PXR with a DC50 value of 85.1 nM and reduces the protein expression of 3xFLAG-PXR.Formule :C58H78N8O13SCouleur et forme :SolidMasse moléculaire :1127.35JPS016
CAS :JPS016: benzamide VHL E3-ligase PROTAC, degrades HDAC1/2, triggers apoptosis in HCT116 cells.Formule :C48H63N7O8SCouleur et forme :SolidMasse moléculaire :898.12TAT-cyclo-CLLFVY
CAS :Blocks HIF-1α/β dimerization, not HIF-2α; suppresses VEGF, CAIX in cancer cells; antiangiogenic in HUVECs (IC50 = 1.3 μM).Formule :C111H188N42O24S2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :2559.1Go6976
CAS :Go6976 is a PKC inhibitor, widely used in research to probe PKC functions in health and disease.Formule :C24H18N4ODegré de pureté :95.89%Couleur et forme :Off-White To Yellow SolidMasse moléculaire :378.43dAurAB2
dAurAB2 is a bifunctional PROTAC capable of effectively degrading Aurora-A and Aurora-B, with DC50 values of 59 nM and 39 nM, respectively. It reduces N-Myc levels in MYCN-amplified IMR32 neuroblastoma cells and is valuable for neuroblastoma research.Couleur et forme :Odour SolidProtein Kinase C (19-31)
CAS :Protein Kinase C (19-31), a PKC inhibitor derived from PKCa, has a serine at position 25 and tests PKC activity.Formule :C67H118N26O16Degré de pureté :98%Couleur et forme :Lyophilized PowderMasse moléculaire :1543.82ZMF-23
ZMF-23, a PAK1/HDAC6 dual inhibitor, suppresses PAK1 and HDAC6-mediated aerobic glycolysis and cellular migration while inducing TNF-α-regulated necroptosis andFormule :C22H23Cl2N5O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :476.36PROTAC BRD4 Degrader-28
PROTAC BRD4 Degrader-28 (Compound 4) is a PROTAC degrader specifically targeting BRD4, and it holds potential for cancer research.Formule :C38H36ClN7O8SCouleur et forme :SolidMasse moléculaire :786.25PROTAC BET Degrader-10
CAS :PROTAC BET Degrader-10 targets and degrades BRD4 with a DC50 of 49 nM, using Cereblon ligands.Formule :C39H39ClN8O6SCouleur et forme :SolidMasse moléculaire :783.3Ref: TM-T39374
200mgÀ demander500mgÀ demander5mg225,00€1mL*10mM (DMSO)309,00€10mg359,00€25mg672,00€50mg999,00€100mg1.485,00€PROTAC MPS1 degrader 1
PROTAC MPS1 degrader 1 (Compound 19) acts as a potent degrader of Monopolar spindle 1 (Mps1, TTK), AURKA, and AURKB, with DC50 values of 17.7, 108.7, and 570.3 nM respectively. It is utilized in the study of acute myeloid leukemia. (Pink: ligand for target protein; Black: linker; Blue: ligand for E3 ligase)Formule :C41H46N12O7Couleur et forme :SolidMasse moléculaire :818.88BT-O2C
CAS :BT-O2C is a highly selective p300 PROTAC degrader that effectively reduces p300 levels in HAP1 cells. It exhibits significant cytotoxicity in CIC:DUX4 sarcoma (CDS) cell lines, with an IC50 of 152-221 nM, and notably decreases the expression of CDS target genes (ETV1, ETV4, ETV5). BT-O2C is applicable in cancer research.Formule :C48H48F5N9O8Couleur et forme :SolidMasse moléculaire :973.94Echinomycin
CAS :Echinomycin (Quinomycin A) is a quinoxaline antibiotic and a DNA-intercalating peptide that inhibits hypoxia-inducible factor-1 (HIF-1) DNA binding activity.Formule :C51H64N12O12S2Degré de pureté :95%Couleur et forme :SolidMasse moléculaire :1101.26TCIP3
CAS :TCIP3 is a bivalent molecular glue (molecular glue) that can simultaneously bind to both p300/CBP and BCL6. It redirects p300 and CBP to activate programmed cell death genes, which are typically repressed by the oncogenic driver BCL6. TCIP3 is useful for studying diffuse large B-cell lymphoma (DLBCL) and is not toxic to untransformed tonsil lymphocytes or fibroblasts.Formule :C58H71ClF2N16O7Couleur et forme :SolidMasse moléculaire :1177.74PROTAC_ERRα
CAS :PROTAC_ERRα is a potent, selective degrader of ERRα, efficiently facilitating its proteasomal degradation.Formule :C46H47F3N6O9S2Couleur et forme :SolidMasse moléculaire :949.03UNC6349 (Ket2)
UNC6349 (Ket2), a ligand containing diethyllysine (Ket2), effectively binds to wild-type CBX5 with a dissociation constant (K D) of 3.2 μM [1].Formule :C41H57N7O11Couleur et forme :SolidMasse moléculaire :823.93LH168
LH168 is a potent and selective probe for WDR5, with a SPR Kd value of 13 nM.Formule :C29H31F3N6O2SCouleur et forme :SolidMasse moléculaire :584.66PROTAC BRD4 Degrader-38
PROTACBRD4 Degrader-38 is a BRD4 PROTAC degrader with DC50 values of 86 nM and 106 nM for the short and long BRD4 isoforms, respectively. It significantly induces BRD4 degradation through covalent binding at the C232 site of the E3 ligase TRIM28.Couleur et forme :Odour SolidM-1211
CAS :M 1121 is a covalent and orally active inhibitor of the menin-MLL interaction capable of achieving complete and persistent tumor regression.Formule :C42H57FN6O6SCouleur et forme :SolidMasse moléculaire :793.01EZH2-IN-5
CAS :EZH2-IN-5, potent EZH2 inhibitor; IC50: 1.52 nM (wild-type), 4.07 nM (Tyr641 mutant).Formule :C26H37BrN4O2Couleur et forme :SolidMasse moléculaire :517.512CP 46665
CAS :CP 46665 is a bio-active chemical.Formule :C35H66Cl2N2O2Couleur et forme :SolidMasse moléculaire :617.82EPZ020411 2HCl (1700663-41-7(free base))
EPZ020411 is an effective and specific small molecule PRMT6 inhibitor (IC50=10 nM).Formule :C25H40Cl2N4O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :515.51LSD1-IN-44
LSD1-IN-44 (Compound 19) is an LSD1 inhibitor with an IC50 of 0.02 μM for the LSD1-CoREST enzyme complex. It exhibits significant antischistosomal activity against newly transformed schistosomula (NTS) and adult Schistosoma mansoni, though its effect on larvae shows some delay. LSD1-IN-44 demonstrates no notable toxicity to human cells and is applicable for schistosomiasis research.Couleur et forme :Odour SolidAMARA peptide
CAS :AMARA peptide: a minimal substrate for SIK, AMPK, and other protein kinases; contains AMPK phosphorylation site.Formule :C62H115N27O17SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :1542.81Menin-KMT2A-IN-1
Menin–KMT2A-IN-1 (Compound 20) is an inhibitor of menin–KMT2A, binding to menin with an IC50 of 8 nM, and disrupting the interaction between menin and lysine methyltransferase 2A (KMT2A). It inhibits hERG channels with an IC50 of 65 μM and suppresses MV4-11 cells with an IC50 of 74 nM. Furthermore, Menin–KMT2A-IN-1 exhibits favorable pharmacokinetic properties in CD-1 mice, with an oral bioavailability of 74%.Formule :C28H35FN6O3Couleur et forme :SolidMasse moléculaire :522.61JPS035
CAS :JPS035: potent benzamide-based VHL E3 ligase PROTAC, degrades HDAC1/2, increases gene expression and apoptosis in HCT116 cells.Formule :C49H65N7O7SCouleur et forme :SolidMasse moléculaire :896.15PROTAC BRD4 Degrader-11
PROTAC BRD4 Degrader-11 links VHL and BRD4 ligands, targeting BRD4 in PC3 cells with STEAP1/CLL1; DC50: 0.23/0.38 nM.Formule :C61H75F2N9O12S4Couleur et forme :SolidMasse moléculaire :1292.56SMD-3236
CAS :SMD-3236 is a PRAOTAC degrader targeting SMARCA2, designed using SMARCA ligand and VHL-1 ligand, and exhibits prolonged anti-tumor activity in vivo. SMARCA2 acts as a synthetic lethal target in cancer cells lacking SMARCA4, with SMD-3236 showing 2000-fold selectivity for SMARCA2 over SMARCA4, having a DC50 of less than 1 nM and a Dmax of over 95%. In the human cancer xenograft models deficient in SMARCA4, notably the H838 model, SMD-3236 effectively induces loss of SMARCA2 in tumor tissue while sparing the SMARCA4 protein, thereby inhibiting tumor growth. The compound consists of a target protein ligand (red part) SMI-1074, a PROTAC linker (black part) (trans-4-Ethynylcyclohexyl)methyl methanesulfonate, and an E3 ligase ligand (blue part) SMARCA2 ligand-14, forming the E3LigaseLigand-linker Conjugate 159.Formule :C61H75ClN10O5SCouleur et forme :SolidMasse moléculaire :1095.83Ac-MBP (1-11)
CAS :Ac-MBP 1-11, a primary encephalitogenic epitope in myelin basic protein (MBP), is a dominant short peptide sequence[1].Formule :C2H3K2OPS3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :248.41HDAC1-IN-9
HDAC1-IN-9 (13c) is an HDAC1 inhibitor. It inhibits the HDAC1 enzyme with an IC50 value of 1.07 µM. This compound exhibits the strongest antiproliferative activity against HT-29 (human colon adenocarcinoma cells), with an IC50 of 1.78 μM. In HCT-116 (human colon cancer cells), HDAC1-IN-9 significantly induces apoptosis. Additionally, HDAC1-IN-9 possesses antiangiogenic properties, reducing the expression levels of VEGFR-2 and phosphorylated VEGFR-2 (pVEGFR-2) by approximately 80%.Formule :C17H17N3O3Couleur et forme :SolidMasse moléculaire :311.34Y16526
Y16526 is a potent inhibitor of the CBP/p300 bromodomain (CBP/p300bromodomain) with an IC50 of 0.03 μM. Y16524 shows potential for research in acute myeloid leukemia (AML).Formule :C30H34FN5O4Couleur et forme :SolidMasse moléculaire :547.62MZP-54
CAS :MZP-54 is a selective degrader of BRD3/4 based on PROTAC technology(Kd of 4 nM for Brd4BD2)Formule :C55H66ClN7O9SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :1036.67Tubulin/HDAC-IN-3
Tubulin/HDAC-IN-3 (compound 12a) serves as a potent dual inhibitor of tubulin polymerization and HDAC1/8, exhibiting IC50 values of 5.4 μM for tubulinFormule :C28H28N2O10Couleur et forme :SolidMasse moléculaire :552.53PKC β pseudosubstrate TFA
PKC β pseudosubstrate TFA is a selective cell-permeable inhibitor of PKC [1] .Formule :C179H295F3N62O40S3Couleur et forme :SolidMasse moléculaire :4108.84CPI-268456
CAS :CPI-268456 is a compound which has bioactive.Formule :C20H15Cl2N3O2Couleur et forme :SolidMasse moléculaire :400.26LSQ-28
LSQ-28 is an orally active HDAC3 inhibitor with an IC50 of 42 nM, demonstrating significant anticancer, antiproliferative, anti-migration, anti-invasion, and anti-wound healing activities. LSQ-28 is suitable for cancer research.Formule :C31H27N5OCouleur et forme :SolidMasse moléculaire :485.579HDAC6-IN-49
HDAC6-IN-49 (Compound 3) is an inhibitor of HDAC, with IC50 values of 0.012 and 0.735 µM against HDAC6 and HDAC1, respectively. Additionally, it inhibits MAO-B, cholinesterase (ChE), histamine receptor (H3R), and serotonin 6 receptor (5-HT6R). HDAC6-IN-49 exhibits neuroprotective effects in SH-SY5Y cells and enhances cognitive functions and motor abilities in fruit fly models of Parkinson's disease and C. elegans models of Alzheimer's disease.Couleur et forme :Odour SolidBRD7-IN-2
BRD7-IN-2 (compound 2-77) is a potent selective inhibitor of bromodomain-containing protein 7 (BRD7), exhibiting significant anti-proliferative activity inFormule :C18H18N2O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :310.35Pulrodemstat HCl
CAS :Pulrodemstat HCl is an LSD1 inhibitor and a KDM1A inhibitor with anticancer anti, proliferative activity.Formule :C24H24ClF2N5O2Degré de pureté :97.87% - 99.16%Couleur et forme :SoildMasse moléculaire :487.93P3FI-63
CAS :P3FI-63 is a selective KDM3B inhibitor (IC50: 7 μM) with antitumor activity for the study of fusion-positive rhabdomyosarcoma and other transcriptionally addictive cancers.Formule :C15H15N3O2Degré de pureté :99.16%Couleur et forme :SoildMasse moléculaire :269.3TNKS-2-IN-2
CAS :TNKS-2-IN-2 is a TNKS2 selective inhibitor (IC50: 22 nM) with potential anti-tumour activity for the study of colon cancer lung cancer and breast cancer.Formule :C26H23N3O6Degré de pureté :99.45%Couleur et forme :SoildMasse moléculaire :473.48PBRM1-BD2-IN-5
CAS :PBRM1-BD2-IN-5 is a potent inhibitor of the PBRM1 Bromodomain, demonstrating dissociation constant (Kd) values of 1.5 μM and 3.9 μM for PBRM1-BD2 and PBRM1-BD5Formule :C15H13ClN2ODegré de pureté :99.51%Couleur et forme :SoildMasse moléculaire :272.73Ref: TM-T60159
1mg84,00€1mL*10mM (DMSO)170,00€5mg177,00€10mg260,00€25mg429,00€50mg572,00€100mg793,00€200mg1.063,00€PCAF-IN-1
CAS :PCAF-IN-1 is a highly selective PCAF inhibitor with potential anti-tumor, anti-inflammatory, and anti-heart disease effects.Formule :C15H11ClN6Couleur et forme :SolidMasse moléculaire :310.74MC4171
MC4171 is a selective KAT8 inhibitor with antiproliferative activity and can be used to study cancer.Formule :C21H15N3O3Degré de pureté :99.56%Couleur et forme :SolidMasse moléculaire :357.36AS-85
CAS :AS-85 is an ASH1L inhibitor with anti-leukemic activity that inhibits leukemic cell growth and increases cLogP.Formule :C26H28F3N5O3S2Degré de pureté :98.96%Couleur et forme :SolidMasse moléculaire :579.66I-BET567
CAS :I-BET567: potent, oral pan-BET inhibitor; pIC50s: 6.9 (BRD4 BD1), 7.2 (BD2); effective in mouse cancer and inflammation models.Formule :C17H18ClN5O2Degré de pureté :99.8%Couleur et forme :SolidMasse moléculaire :359.81Ref: TM-T9619
1mg89,00€5mg187,00€1mL*10mM (DMSO)205,00€10mg286,00€25mg575,00€50mg863,00€100mg1.269,00€DTP3
CAS :DTP3 is a selective MKK7/GADD45β inhibitor, which inhibits cancer-selective NF-κB survival pathway.Formule :C26H35N7O5Couleur et forme :SolidMasse moléculaire :525.6AZ505 ditrifluoroacetate
CAS :AZ505 ditrifluoroacetate is an effective and selective SMYD2 inhibitor (IC50: 0.12 μM).Formule :C33H40Cl2F6N4O8Couleur et forme :SolidMasse moléculaire :805.59GSK778
CAS :GSK778 selectively inhibits BD1 bromodomains (BRD2, BRD3, BRD4, BRDT) and impedes cell growth, causing arrest and apoptosis.Formule :C30H33N5O3Degré de pureté :98.42%Couleur et forme :SolidMasse moléculaire :511.61Ref: TM-T9703
1mL*10mM (DMSO)44,00€1mg152,00€5mg295,00€10mg477,00€25mg954,00€50mg1.513,00€100mg2.097,00€SGC-iMLLT
CAS :SGC-iMLLT is a potent and selective MLLT1/3-histone interactions inhibitor(IC50 = 0.26 μM),and is a first-in-class chemical probe displaying cellular targetFormule :C22H24N6ODegré de pureté :99.21% - 99.92%Couleur et forme :SolidMasse moléculaire :388.47TPOP146
CAS :TPOP146 is a selective CBP/P300 benzoxazepine bromodomain inhibitor (Kd: 134 nM and 5.02 μM for CBP and BRD4).Formule :C27H35N3O5Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :481.58(2R)-Octyl-α-hydroxyglutarate
CAS :(2R)-Octyl-α-hydroxyglutarate ((2R)-Octyl-2-HG) is a D-isomer 2-Hydroxyglutarate modified form.Formule :C13H24O5Couleur et forme :SolidMasse moléculaire :260.33KDM4C-IN-1
CAS :KDM4C-IN-1 is aKDM4C inhibitor withial anticancer activity.KDM4C-IN-1 inhibits the growth of HepG2 and A549 cells, and can be used for the study of leukaemia.Formule :C15H14N4O3Degré de pureté :99.33%Couleur et forme :SolidMasse moléculaire :298.3Eicosapentaenoic Acid (Standard)
CAS :Eicosapentaenoic Acid (Standard) is the standard substance of Eicosapentaenoic Acid, and it is applicable for quantitative analysis, quality control, and related research in biochemical experiments. Eicosapentaenoic Acid is an ω-3 fatty acid and an inhibitor of fatty acid synthase (FASN). Eicosapentaenoic Acid promotes DNA demethylation in the reexpression of the tumor suppressor gene CCAAT/ enhancer-binding protein δ (C/EBPδ). Eicosapentaenoic Acid activates the RAS/ERK/C/EBPβ pathway in U937 leukemia cells through demethylation of the CpG island of H-RAS intron 1. Eicosapentaenoic Acid promotes the relaxation of vascular smooth muscle cells and vasodilation.Formule :C20H30O2Couleur et forme :LiquidMasse moléculaire :302.45EHMT2-IN-1
CAS :EHMT2-IN-1: potent EHMT inhibitor, for blood disorders/cancer research; IC50s <100 nM for EHMT1/2 peptides and cellular EHMT2.Formule :C18H23N7OCouleur et forme :SolidMasse moléculaire :353.42PROTAC EZH2 Degrader-1
CAS :PROTAC EZH2 Degrader-1 suppresses EZH2 methyltransferase activity with IC50 2.7 nM, serving as a potent tool in cancer research and EZH2 inhibition studies.Formule :C54H67N7O8Couleur et forme :SolidMasse moléculaire :942.15PR5-LL-CM01
CAS :PR5-LL-CM01 is a novel protein arginine methyltransferase 5 (PRMT5) inhibitor in colorectal and pancreatic cancers.Formule :C23H27N7Couleur et forme :SolidMasse moléculaire :401.51Itacitinib adipate
CAS :Itacitinib adipate: oral JAK1 inhibitor, tested in phase II myelofibrosis trial.Formule :C32H33F4N9O5Couleur et forme :SolidMasse moléculaire :699.66Ifidancitinib
CAS :Ifidancitinib (ATI-50002) is a JAK kinase 1/3 inhibitor used to study autoimmune diseases.Formule :C20H18FN5O3Degré de pureté :98.05%Couleur et forme :SolidMasse moléculaire :395.39GSK9311
CAS :GSK9311 inhibits BRPF bromodomain (pIC50: 6.0 and 4.3 for BRPF1 and BRPF2, respectively).Formule :C24H31N5O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :437.53GSK2879552
CAS :GSK2879552: oral, irreversible LSD1 inhibitor with potential cancer-fighting properties.Formule :C23H28N2O2Degré de pureté :99.22%Couleur et forme :SolidMasse moléculaire :364.48Boc-Lys(Ac)-AMC
CAS :Boc-Lys(Ac)-AMC (Boc-L-Lys(Ac)-AMC) is a synthetic substrate coupled to an HDAC-specific fluorophore (Ex/Em = 355 nm/460 nm).Formule :C23H31N3O6Degré de pureté :99.87%Couleur et forme :SolidMasse moléculaire :445.51Ref: TM-T36578
5mg51,00€1mL*10mM (DMSO)52,00€10mg77,00€25mg129,00€50mg182,00€100mg268,00€200mg387,00€ADTL-SA1215
CAS :ADTL-SA1215 is a SIRT3 activator with SIRT3 deacetylase activity for the study of triple negative breast cancer.Formule :C26H29I2NO3Degré de pureté :99.23%Couleur et forme :SolidMasse moléculaire :657.32PROTAC PARP1 degrader
CAS :PROTAC PARP1 degrader suppresses MDA-MB-231 cells at 10 μM, IC50: 6.12 μM in 24h.Formule :C58H63Cl2N11O10Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :1145.1T-448
CAS :T-448 is a lysine-specific demethylase 1 inhibitor (IC50: 22 nM) that improves learning function in mice.T-448 can be used to study memory deficits.Formule :C19H22N4O3SDegré de pureté :97% - 98.63%Couleur et forme :SolidMasse moléculaire :386.47JET-209
JET-209 is a potent proteolysis-targeting chimera (PROTAC) that effectively degrades CBP/p300, exhibiting half-maximal degradation concentration (DC50) valuesFormule :C46H47N9O6Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :821.92Atinvicitinib
CAS :Atinvicitinib, a selective JAK1 inhibitor, blocks cytokine signaling, modulating itch, allergy, and inflammatory responses, immune and therapeutic studies.Formule :C16H17FN6O3Degré de pureté :99.36%Couleur et forme :SolidMasse moléculaire :360.35Ref: TM-T39646
1mg138,00€1mL*10mM (DMSO)264,00€5mg334,00€10mg550,00€25mg1.063,00€50mg1.738,00€100mg2.547,00€2'-Deoxy-2'-fluoro-β-D-arabinocytidine hydrochloride
CAS :2'-Deoxy-2'-fluoro-beta-D-arabinocytidine HCl inhibits DNA methyltransferase with potential anti-tumor properties.Formule :C9H13ClFN3O4Degré de pureté :99.43%Couleur et forme :SolidMasse moléculaire :281.67Pim-1/2 kinase inhibitor 1
CAS :Orally active Pim-1/2 inhibitor blocks kinase phosphorylation; used in prostate cancer research.Formule :C11H9NO3SDegré de pureté :99.78%Couleur et forme :SolidMasse moléculaire :235.26PKC-θ inhibitor
CAS :PKC-theta inhibitor is PKC-θinhibitor, with an IC50 of 12 nM.Formule :C20H25F3N6O3Degré de pureté :99.46%Couleur et forme :SolidMasse moléculaire :454.45Ref: TM-T5423
1mg101,00€5mg236,00€1mL*10mM (DMSO)259,00€10mg313,00€25mg442,00€50mg580,00€100mg893,00€200mg1.198,00€HDAC-IN-4
CAS :HDAC-IN-4 is a selective HDAC6 and HDAC10 inhibitor (pIC50s: 7.2 and 6.8 in BRET assay) with antitumoral activity.Formule :C20H21N3O2Couleur et forme :SolidMasse moléculaire :335.4Protein kinase inhibitor H-7 dihydrochloride
CAS :Protein kinase inhibitor H-7 dihydrochloride(H-7 dihydrochloride) is a potent protein kinase C (PKC) inhibitor.Formule :C14H19Cl2N3O2SDegré de pureté :99.81%Couleur et forme :White Crystalline SolidMasse moléculaire :364.29SIRT5 inhibitor 3
CAS :SIRT5 inhibitor 3 is potent and competitive by inhibiting SIRT5 deacetylation, with potential in metabolic, cancer, neurodegenerative, cardiovascular .Formule :C22H12FN3O4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :401.35MS8511 hydrochloride
CAS :MS8511 hydrochloride is a selective G9a/GLP inhibitor with IC50 values of 100 nM and 140 nM respectively, exhibiting covalent and irreversible characteristics.Formule :C28H42ClN5O3Couleur et forme :SolidMasse moléculaire :532.12(±)-1,2-Diolein
CAS :(±)-1,2-Diolein (1,2-Dioleoyl-rac-glycerol) (1,2-Dioleoyl-rac-glycerol) is a PKC activator. (±)-1,2-Diolein could increases myotubes Ca 2+ influx.Formule :C39H72O5Couleur et forme :SolidMasse moléculaire :620.99O6BTG-octylglucoside
CAS :O6BTG-octylglucoside is a potent O6-methylguanine-DNAmethyl-transferase (MGMT) inhibitor (IC50s: 10 nM and 32 nM in HeLa S3 cells and in vitro (cell extracts)).Formule :C24H34BrN5O7SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :616.531,4-DPCA ethyl ester
CAS :1,4-DPCA ethyl ester is a form of 1,4-DPCA modified, which has potential anticancer activity based on growth inhibition assays with the mlh1 rad18 yeast strain.Formule :C15H12N2O3Degré de pureté :99.54%Couleur et forme :SolidMasse moléculaire :268.27Ref: TM-T36796
2mg37,00€5mg54,00€1mL*10mM (DMSO)59,00€10mg90,00€25mg157,00€50mg256,00€100mg434,00€200mg623,00€Ilunocitinib
CAS :Ilunocitinib is a non-selective and orally active Janus kinase (JAK) inhibitor for pruritus and atopic dermatitis caused by atopic dermatitis in dogs.Formule :C17H17N7O2SDegré de pureté :99.88%Couleur et forme :SolidMasse moléculaire :383.43Ref: TM-T38571
1mg92,00€5mg230,00€1mL*10mM (DMSO)251,00€10mg356,00€25mg713,00€50mg1.189,00€100mg1.791,00€200mg2.412,00€GSK-J2
CAS :GSK-J2 is an inactive enantiomer of GSK-J1 that is lipophilic and serves as an inactive control for GSK-J21.Formule :C22H23N5O2Degré de pureté :97.55%Couleur et forme :SolidMasse moléculaire :389.45Ref: TM-T11476
1mg34,00€5mg71,00€10mg92,00€1mL*10mM (DMSO)101,00€25mg157,00€50mg222,00€100mg329,00€200mg487,00€DA-3003-1
CAS :DA-3003-1 (NSC 663284) is a Cdc25 dual specificity phosphatase inhibitor with antitumor activity and inhibits Cdc25B2, Cdc25A, Cdc25B2, and Cdc25C.Formule :C15H16ClN3O3Degré de pureté :99.27% - 99.79%Couleur et forme :SolidMasse moléculaire :321.76CHZ868
CAS :CHZ868 is a type II JAK inhibitor with potential antitumor activity that reverses the persistence of type I JAK inhibitors and can be used to study leukemia.Formule :C22H19F2N5O2Degré de pureté :99.38%Couleur et forme :SolidMasse moléculaire :423.42BAY-850
CAS :BAY-850 is ainhibitor of adenosine triphosphatase family protein 2 that inhibits ovarian cancer growth and metastasis in in vitro and in vivo models.Formule :C38H44ClN5O3Degré de pureté :98% - 98%Couleur et forme :SolidMasse moléculaire :654.24SIRT-IN-3
CAS :SIRT-IN-3: potent SIRT1 inhibitor (IC50=17μM), 4x selective over SIRT2, 14x over SIRT3 (IC50s: 74μM & 235μM).Formule :C13H12N2OCouleur et forme :SolidMasse moléculaire :212.25
